Precision Biosciences Stock Buy Hold or Sell Recommendation
| DTIL Stock | USD 7.26 0.76 11.69% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Precision BioSciences is 'Strong Sell'. The recommendation algorithm takes into account all of Precision BioSciences' available fundamental, technical, and predictive indicators you will find on this site.
Check out Precision BioSciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide. Note, we conduct extensive research on individual companies such as Precision and provide practical buy, sell, or hold advice based on investors' constraints. Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
Precision |
Execute Precision BioSciences Buy or Sell Advice
The Precision recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Precision BioSciences. Macroaxis does not own or have any residual interests in Precision BioSciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Precision BioSciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Slightly risky | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Above Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Precision BioSciences Trading Alerts and Improvement Suggestions
| Precision BioSciences generated a negative expected return over the last 90 days | |
| Precision BioSciences has high historical volatility and very poor performance | |
| Precision BioSciences has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 48.73 M. Net Loss for the year was (61.32 M) with profit before overhead, payroll, taxes, and interest of 25.1 M. | |
| Precision BioSciences currently holds about 184.14 M in cash with (84.11 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.66. | |
| Precision BioSciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Insider Buying John Kelly Acquires Shares of Precision BioSciences Inc |
Precision BioSciences Returns Distribution Density
The distribution of Precision BioSciences' historical returns is an attempt to chart the uncertainty of Precision BioSciences' future price movements. The chart of the probability distribution of Precision BioSciences daily returns describes the distribution of returns around its average expected value. We use Precision BioSciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Precision BioSciences returns is essential to provide solid investment advice for Precision BioSciences.
| Mean Return | -0.39 | Value At Risk | -4.72 | Potential Upside | 5.37 | Standard Deviation | 3.24 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Precision BioSciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Precision Stock Institutional Investors
| Shares | Moloney Securities Asset Management | 2024-09-30 | 31.7 K | Stifel Financial Corp | 2024-06-30 | 30.5 K | Bank Of America Corp | 2024-06-30 | 28.5 K | Tejara Capital Ltd | 2024-06-30 | 24.8 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 21.5 K | Blue Owl Capital Holdings Lp | 2024-09-30 | 20.2 K | Goldman Sachs Group Inc | 2024-06-30 | 15.8 K | Redwood Wealth Management Group Llc | 2024-06-30 | 15.4 K | Ci Private Wealth Llc | 2024-06-30 | 13.8 K | Hhg Plc | 2024-06-30 | 633.1 K | Tang Capital Management Llc | 2024-09-30 | 623.3 K |
Precision BioSciences Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 77.7M | (91.1M) | 53.9M | 45.9M | (72.9M) | (69.3M) | |
| Depreciation | 5.3M | 9.8M | 10.2M | 9.0M | 8.3M | 6.5M | |
| Capital Expenditures | 24.7M | 5.0M | 5.8M | 3.3M | 2.3M | 2.2M | |
| Net Income | (92.9M) | (109.0M) | (30.6M) | (111.6M) | (61.3M) | (64.4M) | |
| End Period Cash Flow | 180.9M | 89.8M | 143.7M | 189.6M | 116.7M | 134.8M | |
| Change To Netincome | 18.9M | 13.8M | (10.1M) | 32.8M | 37.8M | 39.6M | |
| Investments | (24.7M) | (5.0M) | (5.8M) | (3.3M) | 5.2M | 5.4M | |
| Free Cash Flow | (95.7M) | (92.4M) | (16.7M) | (49.1M) | (86.4M) | (90.7M) | |
| Other Non Cash Items | 9.9M | 35K | (20.4M) | 13.6M | (3.6M) | (3.4M) |
Precision BioSciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Precision BioSciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Precision BioSciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Precision stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.49 | |
β | Beta against Dow Jones | 0.76 | |
σ | Overall volatility | 3.26 | |
Ir | Information ratio | -0.16 |
Precision BioSciences Volatility Alert
Precision BioSciences exhibits very low volatility with skewness of 0.69 and kurtosis of 3.64. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Precision BioSciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Precision BioSciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Precision BioSciences Fundamentals Vs Peers
Comparing Precision BioSciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Precision BioSciences' direct or indirect competition across all of the common fundamentals between Precision BioSciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Precision BioSciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Precision BioSciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Precision BioSciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Precision BioSciences to competition |
| Fundamentals | Precision BioSciences | Peer Average |
| Return On Equity | 0.24 | -0.31 |
| Return On Asset | -0.0638 | -0.14 |
| Profit Margin | 0.11 % | (1.27) % |
| Operating Margin | (36.94) % | (5.51) % |
| Current Valuation | (15.2 M) | 16.62 B |
| Shares Outstanding | 7.67 M | 571.82 M |
| Shares Owned By Insiders | 6.50 % | 10.09 % |
| Shares Owned By Institutions | 44.70 % | 39.21 % |
| Number Of Shares Shorted | 214.55 K | 4.71 M |
| Price To Earning | (6.10) X | 28.72 X |
| Price To Book | 0.86 X | 9.51 X |
| Price To Sales | 0.74 X | 11.42 X |
| Revenue | 48.73 M | 9.43 B |
| Gross Profit | 25.1 M | 27.38 B |
| EBITDA | (32.04 M) | 3.9 B |
| Net Income | (61.32 M) | 570.98 M |
| Cash And Equivalents | 184.14 M | 2.7 B |
| Cash Per Share | 1.66 X | 5.01 X |
| Total Debt | 31.27 M | 5.32 B |
| Debt To Equity | 0.27 % | 48.70 % |
| Current Ratio | 4.59 X | 2.16 X |
| Book Value Per Share | 8.67 X | 1.93 K |
| Cash Flow From Operations | (84.11 M) | 971.22 M |
| Short Ratio | 2.57 X | 4.00 X |
| Earnings Per Share | 0.40 X | 3.12 X |
| Target Price | 35.75 | |
| Number Of Employees | 108 | 18.84 K |
| Beta | 1.69 | -0.15 |
| Market Capitalization | 55.69 M | 19.03 B |
| Total Asset | 159.78 M | 29.47 B |
| Retained Earnings | (489.63 M) | 9.33 B |
| Working Capital | 86.37 M | 1.48 B |
| Current Asset | 174.05 M | 9.34 B |
Note: Disposition of 9443 shares by Michael Amoroso of Precision BioSciences subject to Rule 16b-3 [view details]
Precision BioSciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Precision . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Precision BioSciences Buy or Sell Advice
When is the right time to buy or sell Precision BioSciences? Buying financial instruments such as Precision Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Precision BioSciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Large Blend Funds Thematic Idea Now
Large Blend Funds
Fund or Etfs that invest in stocks of large organizations that have characteristics of both growth and value companies. The Large Blend Funds theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Precision BioSciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.4 | Revenue Per Share 12.872 | Quarterly Revenue Growth (0.96) | Return On Assets (0.06) | Return On Equity 0.2444 |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.